Menawat, Dr., Arun

Track

Insider profile

Performance

Overall performance
2.7
Performance over holding periods
2.7
30 days 90 days 120 days
Average return 3% 8.2% 15.1%
Success rate 48% 68% 82%
Transactions
8 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Menawat, Dr., Arun's trades of Profound Medical Corp's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-03-20 2026-03-20
B Purchase
67,445 +39.3%
127.71
US$3,087,647 		67,445 +39.3% 127.71 US$3,087,647
2025-12-23 2025-12-23
B Purchase
85,626 -49.0%
47.90
US$419,131 		85,626 -49.0% 47.90 US$419,131
2025-05-16 2025-05-16
B Purchase
90,008 +46.4%
279.22
US$1,261,005 		90,008 +46.4% 279.22 US$1,261,005
2025-05-16 2025-05-15
B Purchase
10,003 +1.8%
4.33
US$43,263 		10,003 +1.8% 4.33 US$43,263
2025-03-18 2025-03-14
B Purchase
14,200 +2.6%
7.06
US$100,224 		14,200 +2.6% 7.06 US$100,224
2024-12-10 2024-12-10
B Purchase
20,000 +3.7%
7.50
US$150,000 		20,000 +3.7% 7.50 US$150,000
2023-12-22 2023-08-15
B Purchase
24,558 +5.6%
12.95
CA$318,026 		24,558 +5.6% 12.95 CA$318,026
2023-12-22 2023-05-21
B Purchase
12,589 +3.0%
17.41
CA$219,174 		12,589 +3.0% 17.41 CA$219,174
2022-12-20 2022-12-20
B Purchase
13,000 +3.0%
7.81
US$101,486 		13,000 +3.0% 7.81 US$101,486